Pfizer

Good Practices for Creating Reproducible Content From Shiny Apps

Advanced Visual Analytics for Drug Safety Review

Drug safety data present many challenges with regard to curation, analysis, interpretation, and reporting. Safety endpoints have high variability, are multidimensional, and interrelated which points out to a need to identify novel approaches to …

There’s only one R in Pfizer. Attempts to harmonise R release across a large pharma organisation

How do you roll out R to hundreds of colleagues, ensuring that the version you're providing is tested, qualified and well managed? Is it possible to ensure that everyone is using the same version of R and packages? How do you account for differences …

openNCA Pharmacokinetic data repository and Non-compartmental Analysis System

Non-compartmental pharmacokinetic analysis (NCA) is used in the characteristization of drugs absorption, distribution and elimination in the body. Software that implements NCA is available from commercial and non-commercial, open-source, sources. …

Using R in a GxP Environment

The Data Science team in Pfizer’s Vaccine Research and Development division (VRD) creates and maintains validated applications used during high-throughput clinical testing that enable advanced analytic and reporting requirements. SAS has long been …